Minerva R Batugo Selected Research

1-(nitrooxymethyl)-2-(nitrooxy)ethyl 7- (3,5- dihydroxy- 2- (3- hydroxy- 5- phenylpentyl)cyclopentyl)- 5- heptenoate

4/2010

A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Minerva R Batugo Research Topics

Disease

1	Glaucoma 04/2010
1	Ocular Hypertension (Glaucoma, Suspect) 04/2010

Drug/Important Bio-Agent (IBA)

1	1-(nitrooxymethyl)-2-(nitrooxy)ethyl 7- (3,5- dihydroxy- 2- (3- hydroxy- 5- phenylpentyl)cyclopentyl)- 5- heptenoateIBA 04/2010
1	Latanoprost (Xalatan)FDA Link 04/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2010
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 04/2010

Therapy/Procedure

1	Lasers (Laser) 04/2010